ID: ALA4531537

Max Phase: Preclinical

Molecular Formula: C13H15BrN2O

Molecular Weight: 295.18

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCC(=O)NCCn1c(Br)cc2ccccc21

Standard InChI:  InChI=1S/C13H15BrN2O/c1-2-13(17)15-7-8-16-11-6-4-3-5-10(11)9-12(16)14/h3-6,9H,2,7-8H2,1H3,(H,15,17)

Standard InChI Key:  OQUBELQAULVUBC-UHFFFAOYSA-N

Associated Targets(Human)

Melatonin receptor 989 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 295.18Molecular Weight (Monoisotopic): 294.0368AlogP: 2.93#Rotatable Bonds: 4
Polar Surface Area: 34.03Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.49CX LogD: 2.49
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.92Np Likeness Score: -1.40

References

1. Wang SY, Shi XC, Laborda P..  (2020)  Indole-based melatonin analogues: Synthetic approaches and biological activity.,  185  [PMID:31727472] [10.1016/j.ejmech.2019.111847]

Source